|
|
Volumn 16, Issue 2, 2002, Pages 235-242
|
|
Pharmacokinetics and biochemical effects of hepapoietin in patients with chronic liver disease
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMIN;
AMMONIA;
BILIRUBIN;
CHOLESTEROL;
CYTOKINE;
HEMOGLOBIN;
HEPATOPOIETIN;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
SCATTER FACTOR;
ADULT;
ALBUMIN BLOOD LEVEL;
AMMONIA BLOOD LEVEL;
ARTICLE;
BILIRUBIN BLOOD LEVEL;
CHOLESTEROL BLOOD LEVEL;
CHRONIC LIVER DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG FORMULATION;
DRUG SAFETY;
DRUG SCREENING;
ERYTHROCYTE COUNT;
FEMALE;
FOLLOW UP;
HEMOGLOBIN DETERMINATION;
HEPATIC ENCEPHALOPATHY;
HUMAN;
LIVER FUNCTION TEST;
MALE;
PARTIAL THROMBOPLASTIN TIME;
PHARMACOKINETICS;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
SCORING SYSTEM;
SIDE EFFECT;
AREA UNDER CURVE;
CHRONIC DISEASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HEPATOCYTE GROWTH FACTOR;
HUMANS;
LIVER DISEASES;
LIVER FUNCTION TESTS;
MALE;
METABOLIC CLEARANCE RATE;
MIDDLE AGED;
|
|
EID: 0036171877
PISSN: 02692813
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2036.2002.01110.x Document Type: Article |
|
Times cited : (8)
|
|
References (14)
|
